GL1X · GenesisL1 explorer

Research workbench

Crystal structure of leishmania major N-myristoyltransferase (nmt) with bound myristoyl-CoA and a pyrazole sulphonamide ligand

Analyse Crystal structure of leishmania major N-myristoyltransferase (nmt) with bound… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4A30
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
QMI, MYA, CL
Pockets
3 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41132% helix, 27% strandQ4Q5S8

Ligands and binding sites

  • QMI · 4-bromo-2,6-dichloro-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)benzenesulfonamide · ligand · chains A
  • MYA · Tetradecanoyl-coa · ligand · chains A
  • CL · Chloride ion · ion · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19450.790.8188CL, QMI, MYA
2620.730.9822GOL
31340.430.7627empty

Compared structures

  • 4A30 · Crystal structure of leishmania major N-myristoyltransferase (nmt) with bound… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.